AstraZeneca PLC - Common Stock - Foreign

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / Common Stock - Foreign
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
28,963
Holdings value
$4,357,628
% of all portfolios
0%
Number of holders
2
Number of buys
2
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AstraZeneca PLC - Common Stock - Foreign

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 28,963 $4,357,628 +$480,006 $150.46 2
2025 Q2 25,774 $3,577,918 +$2,125,489 $138.8 2
2025 Q1 10,473 $1,521,339 -$954,151 $145.32 2
2024 Q4 17,744 $2,326,248 +$718,295 $131.1 3
2024 Q3 12,265 $1,906,384 +$5,112 $155.18 2
2024 Q2 12,232 $1,910,542 -$343,623 $156.19 2
2024 Q1 14,432 $1,946,726 -$103,599 $134.84 2
2023 Q4 15,200 $2,053,957 -$30,404 $135.13 1
2023 Q3 15,425 $2,090,171 +$2,090,171 $135.51 1
2023 Q1 0 $0 -$1,066,846 0
2022 Q4 7,906 $1,066,846 +$135,751 $134.94 1
2022 Q3 6,900 $765,933 $111 1
2022 Q2 6,900 $905,008 -$498,410 $131.16 1
2022 Q1 10,700 $1,427,412 $133.4 1
2021 Q4 10,700 $1,257,669 $117.54 1
2021 Q3 10,700 $1,292,402 +$1,292,402 $120.79 1
2015 Q3 0 $0 -$66,894,000 0
2015 Q2 1,058,338 $66,894,000 -$81,504,154 $63.21 1
2015 Q1 2,347,825 $161,249,000 +$118,346,083 $68.68 1
2014 Q4 624,677 $44,372,000 +$44,372,000 $71.03 1
2014 Q3 0 $0 -$657,000 0
2014 Q2 8,850 $657,000 +$657,000 $74.24 1
2014 Q1 0 $0 -$480,000 0